[ad_1]
The company expects to launch a round of financing in 2022
Lifespin GmbH is an in-depth data company that is currently developing a proprietary health test platform based on artificial intelligence to measure quantitative metabolic data in patient samples. It has received 2.5 million euros in bridging financing to promote the company’s continuous product development .
This press release features multimedia. View the full version here: https://www.businesswire.com/news/home/20211213005059/en/
An individual’s metabolic status is quantitatively measured using NMR, and processed using lifespin™’s proprietary advanced artificial intelligence (AI) and deep learning algorithms to determine health conditions and diagnose diseases, and the results are provided through the cloud. (Photo: Lifespin Co., Ltd.)
The Lifespin platform is based on mapping human health metabolomics and converting this data into health information, which can be deployed in a wide range of pharmaceutical, research,…
The full story can be found on Benzinga.com
[ad_2]
Source link
